{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:44:07Z","timestamp":1779205447307,"version":"3.51.4"},"reference-count":54,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2018.8905","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T09:10:41Z","timestamp":1524215441000},"source":"Crossref","is-referenced-by-count":11,"title":["Combined inhibition of JAK1,2\/Stat3\u2011PD\u2011L1 signaling pathway suppresses the immune escape of castration\u2011resistant prostate cancer to NK cells in hypoxia"],"prefix":"10.3892","author":[{"given":"Li\u2011Jun","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[{"name":"First Department of Urology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo\u2011Xin","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan\u2011Yang","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya\u2011Chen","family":"Zang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi\u2011Bin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong\u2011Rong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2011Xi","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,4,20]]},"reference":[{"key":"key20200713225508_b1-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.eururo.2016.08.002","article-title":"EAU-ESTRO-SIOG Guidelines on prostate cancer. Part II: Treatment of relapsing, metastatic, and castration-resistant prostate cancer","volume":"71","author":"Cornford","year":"2017","journal-title":"Eur Urol"},{"key":"key20200713225508_b2-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.juro.2015.10.086","article-title":"Castration-resistant prostate cancer: AUA Guideline Amendment 2015","volume":"195","author":"Lowrance","year":"2016","journal-title":"J Urol"},{"key":"key20200713225508_b3-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.juro.2015.06.106","article-title":"Treating patients with metastatic castration resistant prostate cancer: A comprehensive review of available therapies","volume":"194","author":"Crawford","year":"2015","journal-title":"J Urol"},{"key":"key20200713225508_b4-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/sca.21174","article-title":"Monitoring changes of tumor microenvironment in colorectal submucosa using multiphoton microscopy","volume":"37","author":"Qiu","year":"2015","journal-title":"Scanning"},{"key":"key20200713225508_b5-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1016\/j.semcancer.2015.02.007","article-title":"Cancer prevention and therapy through the modulation of the tumor microenvironment","volume":"35","author":"Casey","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"key20200713225508_b6-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.abb.2016.11.002","article-title":"Impact of hypoxia inducible factors on estrogen receptor expression in breast cancer cells","volume":"613","author":"Wolff","year":"2017","journal-title":"Arch Biochem Biophys"},{"key":"key20200713225508_b7-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"7419","DOI":"10.3892\/mmr.2015.4410","article-title":"Upregulation of extracellular matrix metalloproteinase inducer promotes hypoxia-induced epithelial-mesenchymal transition in esophageal cancer","volume":"12","author":"Wu","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20200713225508_b8-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12094-016-1541-x","article-title":"Predictive value of hypoxia in advanced head and neck cancer after treatment with hyperfractionated radio-chemotherapy and hypoxia modification","volume":"19","author":"Clavo","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"key20200713225508_b9-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2016.03.030","article-title":"PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells","volume":"81","author":"Li","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"key20200713225508_b10-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3892\/or.2016.4766","article-title":"Hypoxia inducible factor-1\u03b1-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells","volume":"36","author":"Li","year":"2016","journal-title":"Oncol Rep"},{"key":"key20200713225508_b11-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.12659\/MSM.896832","article-title":"Hypoxia-responsive Mir-301a and Mir-301b promote radioresistance of prostate cancer cells via downregulating NDRG2","volume":"22","author":"Wang","year":"2016","journal-title":"Med Sci Monit"},{"key":"key20200713225508_b12-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1476-4598-12-27","article-title":"Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia","volume":"12","author":"Nomura","year":"2013","journal-title":"Mol Cancer"},{"key":"key20200713225508_b13-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1158\/0008-5472.CAN-14-2598","article-title":"Mechanisms of hypoxia-mediated immune escape in cancer","volume":"74","author":"Barsoum","year":"2014","journal-title":"Cancer Res"},{"key":"key20200713225508_b14-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.4049\/jimmunol.1302140","article-title":"Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-\u03b21","volume":"191","author":"Hasmim","year":"2013","journal-title":"J Immunol"},{"key":"key20200713225508_b15-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1158\/0008-5472.CAN-12-1383","article-title":"Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells","volume":"72","author":"Noman","year":"2012","journal-title":"Cancer Res"},{"key":"key20200713225508_b16-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.3892\/mmr.2015.3144","article-title":"Hypoxia-mediated immune evasion of pancreatic carcinoma cells","volume":"11","author":"Lu","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20200713225508_b17-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3892\/ijo.2012.1630","article-title":"Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1\u03b1-dependent manner","volume":"41","author":"Yamada","year":"2012","journal-title":"Int J Oncol"},{"key":"key20200713225508_b18-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"e64835","DOI":"10.1371\/journal.pone.0064835","article-title":"Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells","volume":"8","author":"Sarkar","year":"2013","journal-title":"PLoS One"},{"key":"key20200713225508_b19-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1053\/j.seminoncol.2015.02.009","article-title":"Immune response regulation in the tumor microenvironment by hypoxia","volume":"42","author":"Labiano","year":"2015","journal-title":"Semin Oncol"},{"key":"key20200713225508_b20-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00345-012-0848-7","article-title":"Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer","volume":"31","author":"Hamilton","year":"2013","journal-title":"World J Urol"},{"key":"key20200713225508_b21-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1158\/0008-5472.CAN-08-0054","article-title":"Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: Role of nitric oxide","volume":"68","author":"Siemens","year":"2008","journal-title":"Cancer Res"},{"key":"key20200713225508_b22-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1158\/0008-5472.CAN-14-2598","article-title":"A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells","volume":"74","author":"Barsoum","year":"2014","journal-title":"Cancer Res"},{"key":"key20200713225508_b23-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/annonc\/mdv615","article-title":"Regulation of PD-L1: A novel role of pro-survival signalling in cancer","volume":"27","author":"Chen","year":"2016","journal-title":"Ann Oncol"},{"key":"key20200713225508_b24-mmr-17-06-8111","first-page":"85","article-title":"Effect of soluble PD-L1 released by lung cancer cells in regulating the function of T lymphocytes","volume":"35","author":"Shi","year":"2013","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"key20200713225508_b25-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1158\/2159-8290.CD-13-0310","article-title":"Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors","volume":"3","author":"Akbay","year":"2013","journal-title":"Cancer Discov"},{"key":"key20200713225508_b26-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.clinthera.2015.02.018","article-title":"The next immune-checkpoint inhibitors: PD-1\/PD-L1 blockade in melanoma","volume":"37","author":"Mahoney","year":"2015","journal-title":"Clin Ther"},{"key":"key20200713225508_b27-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s10147-016-0968-y","article-title":"Anti-PD-L1\/PD-1 immune therapies in ovarian cancer: Basic mechanism and future clinical application","volume":"21","author":"Mandai","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"key20200713225508_b28-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2217\/fon.15.337","article-title":"The PD-1\/PD-L1 axis in the pathogenesis of urothelial bladder cancer and evaluating its potential as a therapeutic target","volume":"12","author":"Bardoli","year":"2016","journal-title":"Future Oncol"},{"key":"key20200713225508_b29-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/S1470-2045(14)71167-2","article-title":"Anti-PD-L1 antibody active in metastatic bladder cancer","volume":"16","author":"Brower","year":"2015","journal-title":"Lancet Oncol"},{"key":"key20200713225508_b30-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/1078-0432.CCR-15-1543","article-title":"Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma","volume":"22","author":"Vassilakopoulou","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20200713225508_b31-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/PPO.0000000000000060","article-title":"PD-1 as an immune modulatory receptor","volume":"20","author":"Yao","year":"2014","journal-title":"Cancer J"},{"key":"key20200713225508_b32-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"e0134715","DOI":"10.1371\/journal.pone.0134715","article-title":"The PD-1\/B7-H1 pathway modulates the natural killer cells versus mouse glioma stem cells","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"key":"key20200713225508_b33-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bbrc.2015.04.119","article-title":"SIRT1 deacetylates and stabilizes hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) via direct interactions during hypoxia","volume":"462","author":"Joo","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713225508_b34-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3892\/or.2017.5399","article-title":"The JAK\/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines","volume":"37","author":"Doi","year":"2017","journal-title":"Oncol Rep"},{"key":"key20200713225508_b35-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"e1008824","DOI":"10.1080\/2162402X.2015.1008824","article-title":"Interferon-\u03b3-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression","volume":"4","author":"Bellucci","year":"2015","journal-title":"Oncoimmunology"},{"key":"key20200713225508_b36-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1158\/1078-0432.CCR-13-2797","article-title":"Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma","volume":"20","author":"Atefi","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20200713225508_b37-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/IGC.0000000000000875","article-title":"Posttranscriptional control of PD-L1 expression by 17\u03b2-estradiol via PI3K\/Akt signaling pathway in ER\u03b1-positive cancer cell lines","volume":"27","author":"Yang","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"key20200713225508_b38-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/1078-0432.CCR-12-2731","article-title":"The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibition","volume":"19","author":"Jiang","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20200713225508_b39-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"e0123410","DOI":"10.1371\/journal.pone.0123410","article-title":"Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-\u03baB","volume":"10","author":"Gowrishankar","year":"2015","journal-title":"PLoS One"},{"key":"key20200713225508_b40-mmr-17-06-8111","first-page":"7858","article-title":"Estimating high-risk castration resistant prostate cancer (CRPC) using electronic health records","volume":"22","author":"Hernandez","year":"2015","journal-title":"Can J Urol"},{"key":"key20200713225508_b41-mmr-17-06-8111","first-page":"2103","article-title":"Evaluation and diagnosis for castration resistant prostate cancer: CRPC","volume":"72","author":"Kamoto","year":"2014","journal-title":"Nihon Rinsho"},{"key":"key20200713225508_b42-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1089\/ars.2013.5378","article-title":"The clinical importance of assessing tumor hypoxia: Relationship of tumor hypoxia to prognosis and therapeutic opportunities","volume":"21","author":"Walsh","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"key20200713225508_b43-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.bbagen.2014.10.025","article-title":"The circadian clock and hypoxia in tumor cell de-differentiation and metastasis","volume":"1850","author":"Jensen","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"key20200713225508_b44-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D receptor and its ligands in host defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"key20200713225508_b45-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.molimm.2015.02.009","article-title":"Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy","volume":"67","author":"Swaika","year":"2015","journal-title":"Mol Immunol"},{"key":"key20200713225508_b46-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway","volume":"21","author":"Ohaegbulam","year":"2015","journal-title":"Trends Mol Med"},{"key":"key20200713225508_b47-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s10753-015-0135-z","article-title":"The specific roles of JAK\/STAT signaling pathway in sepsis","volume":"38","author":"Cai","year":"2015","journal-title":"Inflammation"},{"key":"key20200713225508_b48-mmr-17-06-8111","first-page":"e28086","article-title":"The involvement of JAK-STAT3 in cell motility, invasion, and metastasis","volume":"3","author":"Teng","year":"2014","journal-title":"JAKSTAT"},{"key":"key20200713225508_b49-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O'Shea","year":"2013","journal-title":"N Engl J Med"},{"key":"key20200713225508_b50-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3892\/ijo.2014.2259","article-title":"The IL-6\/JAK\/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer (Review)","volume":"44","author":"Wang","year":"2014","journal-title":"Int J Oncol"},{"key":"key20200713225508_b51-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3892\/ijo.2014.2310","article-title":"JAK\/STAT3 signaling is required for TGF-\u03b2-induced epithelial-mesenchymal transition in lung cancer cells","volume":"44","author":"Liu","year":"2014","journal-title":"Int J Oncol"},{"key":"key20200713225508_b52-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.1158\/0008-5472.CAN-14-0160","article-title":"Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak\/STAT3 signaling","volume":"74","author":"Lapeire","year":"2014","journal-title":"Cancer Res"},{"key":"key20200713225508_b53-mmr-17-06-8111","first-page":"1250","article-title":"JAK\/STAT pathway interacts with intercellular cell adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM) while prostate cancer stem cells form tumor spheroids","volume":"20","author":"Duzagac","year":"2015","journal-title":"J BUON"},{"key":"key20200713225508_b54-mmr-17-06-8111","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/annonc\/mdw217","article-title":"Immune escape to PD-L1\/PD-1 blockade: Seven steps to success (or failure)","volume":"27","author":"Kim","year":"2016","journal-title":"Ann Oncol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T22:58:45Z","timestamp":1594681125000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2018.8905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,20]]},"references-count":54,"URL":"https:\/\/doi.org\/10.3892\/mmr.2018.8905","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,20]]}}}